Sterling Capital Management’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-259	Closed	-$357	–	3394
2025 Q1	$357	Sell	259 -221	-46%	-$305	﹤0.01%	3013
2024 Q4	$1.46K	Buy	480 +412	+606%	+$1.25K	﹤0.01%	2865
2024 Q3	$339	Buy	+68	New	+$339	﹤0.01%	3002